While initially elevated platelet expression of integrins GPIIb (CD41) and GPIIIa (CD61) was reported in COVID-19 (20), a larger study found no GPIIb/IIIa alterations in acute or convalescent COVID-19 patients (32). Here, ITGB3 is linked to COVID-19.